Literature DB >> 18705474

Primary hyperparathyroidism in Saudi Arabia: a review of 46 cases.

U H Malabu1, M A Founda.   

Abstract

Records of 46 patients who were treated for primary hyperparathyroidism at King Khalid University Hospital, Riyadh Saudi Arabia from 1st July 2000 to 30th June 2006 were reviewed. Mean age at diagnosis was 44 years (range 13-70 years) and average duration of symptoms was 39 months (1 month to 11 years). There were 35 females and 11 males with a ratio of 3.2:1. Bone pains were the major symptoms at presentation in 45.7% followed by no symptom in 23.9%, renal stones in 15.2%, polyuria in 6.5%, while 4.3% each presented with depression, and constipation. Males had significantly more severe disease with higher serum calcium, higher urinary calcium excretion, and higher serum creatinine. Ninety six percent of patients had successful surgery and 4% (two patients) each had recurrence and hungry bone syndrome. It is concluded that PHPT in Saudi Arabia continues to be a symptomatic disorder with skeletal and renal manifestations occurring at a younger age and males having more severe disease. Further prospective studies are needed to verify our findings.

Entities:  

Mesh:

Year:  2007        PMID: 18705474

Source DB:  PubMed          Journal:  Med J Malaysia        ISSN: 0300-5283


  10 in total

1.  Primary hyperparathyroidism in Saudi Arabia revisited: a multi-centre observational study.

Authors:  Yousef Al-Saleh; Abdullah AlSohaim; Reem AlAmoudi; Ali AlQarni; Raed Alenezi; Layla Mahdi; Hend Alzanbaqi; Samah M Nawar; Hibah AlHarbi; Abdulrhman ALMulla; Maryam Al Qahtani; Salih Bin Salih; Faisal Al Anazi; Najla Saleh; Seham Saleh; Ali AlAklabi; Shaun Sabico; Nasser M Al-Daghri
Journal:  BMC Endocr Disord       Date:  2022-06-09       Impact factor: 3.263

Review 2.  Primary hyperparathyroidism.

Authors:  John P Bilezikian; Natalie E Cusano; Aliya A Khan; Jian-Min Liu; Claudio Marcocci; Francisco Bandeira
Journal:  Nat Rev Dis Primers       Date:  2016-05-19       Impact factor: 52.329

3.  Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop.

Authors:  Shonni J Silverberg; Bart L Clarke; Munro Peacock; Francisco Bandeira; Stephanie Boutroy; Natalie E Cusano; David Dempster; E Michael Lewiecki; Jian-Min Liu; Salvatore Minisola; Lars Rejnmark; Barbara C Silva; Marcella D Walker; John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2014-08-27       Impact factor: 5.958

Review 4.  Primary hyperparathyroidism.

Authors:  Marcella D Walker; Shonni J Silverberg
Journal:  Nat Rev Endocrinol       Date:  2017-09-08       Impact factor: 43.330

5.  Preoperative zoledronic acid therapy prevent hungry bone syndrome in patients with primary hyperparathyroidism.

Authors:  Sabaretnam Mayilvaganan; H A Vijaya Sarathi; C Shivaprasad
Journal:  Indian J Endocrinol Metab       Date:  2017 Jan-Feb

6.  Risk factors of developing the hungry bone syndrome after parathyroidectomy for primary hyperparathyroidism.

Authors:  Matas Jakubauskas; Virgilijus Beiša; Kęstutis Strupas
Journal:  Acta Med Litu       Date:  2018

7.  Lessons learned from the management of Hungry Bone Syndrome following the removal of an Atypical Parathyroid Adenoma.

Authors:  Dimos Florakis; Stavros Karakozis; Sophia Tseleni-Balafouta; Polyzois Makras
Journal:  J Musculoskelet Neuronal Interact       Date:  2019-09-01       Impact factor: 2.041

8.  Monocentric experience of primary hyperparathyroidism surgery in Algeria.

Authors:  Souad Nouikes Zitouni
Journal:  Surg Open Sci       Date:  2021-02-10

9.  Clinical Characterization of Post-parathyroidectomy Patients with Primary Hyperparathyroidism and the Concordance of Preoperative Localization Imaging with Histopathology at a Tertiary Hospital in Manila, Philippines.

Authors:  Danica Francisco; Elizabeth Paz-Pacheco; Perie Adorable-Wagan
Journal:  J ASEAN Fed Endocr Soc       Date:  2020-05-04

10.  Giant versus regular parathyroid adenoma: A retrospective comparative study.

Authors:  Wisam Algargaz; Hassan M Abushukair; Haitham Odat; Shadi Hamouri; Raneem Abuashour
Journal:  Ann Med Surg (Lond)       Date:  2021-05-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.